TY - JOUR
T1 - Postmenopausal hormone use, screening, and breast cancer
T2 - Characterization and control of a bias
AU - Joffe, Marshall M.
AU - Byrne, Celia
AU - Colditz, Graham A.
PY - 2001
Y1 - 2001
N2 - Previous investigators have suggested that screening-related biases may explain associations between postmenopausal hormone use and breast cancer. To investigate these biases, we studied postmenopausal women in the Nurses' Health Study from 1988 to 1994. Hormone use is associated with increased subsequent screening. Among women not screened in the previous 2 years, the probability difference, comparing current hormone users with others, for having mammography in the following 2 years is 19.5%; among women previously screened, the difference is 4.9%. These differences persist after control for other factors. If the increase in screening is causal, screening by mammogram could be intermediate in the causal pathway to breast cancer diagnosis. To deal with this problem, we restrict attention to a subset of the cohort in which the effect of postmenopausal hormone use on screening is small (women previously screened). In this subset, the rate ratio comparing breast cancer rates among current postmenopausal hormone users with others is 1.28. In a sensitivity analysis, the bias could not by itself plausibly account for the associations in our data. Our data provide evidence of an association between post=menopausal hormone use and breast cancer that is not solely the product of a detection bias.
AB - Previous investigators have suggested that screening-related biases may explain associations between postmenopausal hormone use and breast cancer. To investigate these biases, we studied postmenopausal women in the Nurses' Health Study from 1988 to 1994. Hormone use is associated with increased subsequent screening. Among women not screened in the previous 2 years, the probability difference, comparing current hormone users with others, for having mammography in the following 2 years is 19.5%; among women previously screened, the difference is 4.9%. These differences persist after control for other factors. If the increase in screening is causal, screening by mammogram could be intermediate in the causal pathway to breast cancer diagnosis. To deal with this problem, we restrict attention to a subset of the cohort in which the effect of postmenopausal hormone use on screening is small (women previously screened). In this subset, the rate ratio comparing breast cancer rates among current postmenopausal hormone users with others is 1.28. In a sensitivity analysis, the bias could not by itself plausibly account for the associations in our data. Our data provide evidence of an association between post=menopausal hormone use and breast cancer that is not solely the product of a detection bias.
KW - Bias
KW - Breast neoplasms
KW - Causality
KW - Epidemiologic methods
KW - Mammography
KW - Postmenopausal hormone replacement
UR - http://www.scopus.com/inward/record.url?scp=0034990708&partnerID=8YFLogxK
U2 - 10.1097/00001648-200107000-00013
DO - 10.1097/00001648-200107000-00013
M3 - Article
C2 - 11416781
AN - SCOPUS:0034990708
SN - 1044-3983
VL - 12
SP - 429
EP - 438
JO - Epidemiology
JF - Epidemiology
IS - 4
ER -